newsfilter
← Latest News
Business Wire·

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

Researchers found 70% of compounds designed in ADMET Predictor demonstrated significant activity during in vitro testing Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics,